PHSRX Mutual Fund

NAV$53.99

Fund Essentials - as of Dec 31, 2025

Net Assets
-
Expense Ratio
1.29%
Dividend Yield (Current)
0.18%
Holdings
43
Inception Date
Jan 21, 2003
Fund Family
Putnam Investments
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+3.95%
1 Year+11.91%
3 Year+12.25%
5 Year+10.66%
10 Year+10.97%

Asset Allocation

Stocks: 98.92%
Bonds: 0.12%
Cash: 0.94%
Other: 0.02%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co12.50%
JNJJohnson & Johnson7.97%
ABBVAbbvie Inc7.03%
UNHUnitedHealth Group Incorporated5.25%
AZN:LNAstrazeneca Plc5.25%
Top 10 Concentration: 58.38%Report Date: Dec 31, 2025
Download all 43 holdings for PHSRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.18%
Frequency
Annually
Latest Distribution
$5.50
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

PHSRX Mutual Fund Overview

PHSRX Mutual Fund (Putnam Global Health Care Fund Class R) is managed by Putnam Investments. PHSRX expense ratio is 1.29%, holding 43 positions across sectors including Health Care, Unknown, Other. Inception date: 2003-01-21.

PHSRX performance shows a YTD return of 3.95%. The 1-year return is 11.91% and the 5-year return is 10.66%. PHSRX dividend yield stands at 0.18%, paid annually.

PHSRX top holdings include Eli Lilly & Co (12.5%), Johnson & Johnson (8.0%), Abbvie Inc (7.0%), UnitedHealth Group Incorporated (5.3%), Astrazeneca Plc (5.3%). View all PHSRX holdings, sector breakdown, or dividend history.

PHSRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. PHSRX alternatives are available via the screener, along with tax-loss harvesting opportunities.